cbdMD, Inc. (YCBD) - Dilution Analysis

10-Q filing | 10.4M shares outstanding

8-K filing: On April 14, 2026, cbdMD, Inc. issued 1,572 restricted stock units (RSUs) to each independent director and the non-management employee director as compensation for services, vesting quarterly beginning June 30, 2026.

S-1 filing: This S-1 filing from cbdMD, Inc. relates to the potential resale of up to 2,000,000 shares of common stock by selling shareholders, issuable upon conversion of Series C Convertible Preferred Stock.

8-K filing: cbdMD, Inc. acquired substantially all of Gaia Botanicals, LLC's assets for 425,000 shares of cbdMD, Inc.'s restricted common stock issued on the closing and an earnout amount of up to 525,000 shares of cbdMD, Inc.'s restricted common stock.

S-1/A filing: This S-1/A filing from cbdMD, Inc. relates to the potential resale of up to 1,700,000 shares of common stock by selling shareholders, issuable upon conversion of Series B Convertible Preferred Stock.

10-K filing | 8.9M shares outstanding

S-1 filing: This prospectus relates to the potential resale from time to time of up to 1,700,000 shares of our common stock by the selling shareholders identified herein, issuable upon conversion of shares of our Series B Convertible Preferred Stock.

8-K filing: cbdMD, Inc. issued 1,700,000 shares of Series B Convertible Preferred Stock to four institutional investors for gross proceeds of $1,700,000 and net proceeds of $1,500,000, which will be used for working capital purposes. ($1.7M proceeds)

10-Q filing | 8.9M shares outstanding

8-K filing: On May 16, 2025, cbdMD, Inc. issued 1,572 restricted stock units to each independent director and the non-management employee director as compensation for services.

10-Q filing | 0.8M shares outstanding

8-K filing: The company enacted a one-for-8 reverse stock split of its common stock effective May 6, 2025, and completed an automatic conversion of preferred stock into 65,000,000 shares of common stock.

10-Q filing | 5.5M shares outstanding

8-K filing: Remaining outstanding Senior Secured Convertible Notes in the amount of approximately $56,000 were converted into 6,262,833 shares of the Company's common stock as of January 14, 2025.

8-K filing: The company issued 609,717 shares of common stock pursuant to the partial conversion of Senior Secured Convertible Notes, reducing the aggregate balances on such notes by approximately $309,000.

10-K filing | 4.3M shares outstanding

8-K filing: cbdMD, Inc. entered into a Second Amendment to Lease to extend the Warehouse Lease for nineteen months beginning on March 1, 2025, and issued an aggregate of 627,011 shares of its common stock pursuant to the partial conversion of its outstanding Senior Secured Convertible Notes during September, October and November 2024.

8-K filing: cbdMD, Inc. entered into an agreement to acquire the Limited Mark from Majik Medicine, LLC, issuing 75,000 shares of common stock to Majik on August 23, 2024, with an additional 50,000 shares to be issued on the one-year anniversary, and other considerations.

10-Q filing | 3.6M shares outstanding

10-Q filing | 3.0M shares outstanding

8-K filing: Appointment of Scott Stephen as Chairman of the Board, T. Ronan Kennedy as CEO and CFO, and Brad Whitford as Chief Accounting Officer, Treasurer and Secretary, along with equity grants to board members consisting of restricted stock units and stock options.

S-1/A filing: The filing relates to the sale of up to 5,138,890 shares of common stock by selling shareholders, issuable pursuant to Convertible Notes.

S-1 filing: S-1 filing for the sale of up to 5,138,890 shares of common stock by selling shareholders.

10-Q filing | 3.0M shares outstanding

10-K filing | 3.0M shares outstanding

10-Q filing | 2.9M shares outstanding

10-Q filing | 1.3M shares outstanding

8-K filing: cbdMD, Inc. completed an offering of 1,350,000 shares of common stock at a price of $2.10 per share, resulting in net proceeds of approximately $2.5 million. The underwriter also received a warrant to purchase up to 40,500 shares of common stock at $2.52 per share. ($2.84M proceeds)

8-K filing: Stock split 1-for-45 | Outstanding: 60,357,449 → 1,339,935

S-1 filing: This S-1 filing registers 13,079,394 shares of common stock for sale by the selling stockholder, Keystone Capital Partners, LLC.

8-K filing: cbdMD, Inc. entered into a common stock purchase agreement with Keystone Capital Partners, LLC, allowing the Company to sell up to 12,687,012 shares of common stock to Keystone over a 12-month period, and issued 392,382 commitment shares.

10-Q filing | 60.4M shares outstanding

8-K filing: cbdMD, Inc. entered into an agreement with a360 Media, LLC for advertising placement in exchange for up to 6,060,606 shares of the Company's common stock valued at $0.33 per share. ($2.0M proceeds)

10-K filing | 59.8M shares outstanding

10-Q filing | 59.3M shares outstanding

8-K filing: On May 17, 2022, cbdMD, Inc. issued an aggregate of 458,877 shares of its common stock to members of CBD Holding, LLC as part of the merger consideration related to the Cure Based Development merger.

10-Q filing | 59.0M shares outstanding

S-3 filing: cbdMD, Inc. may offer and sell, from time to time in one or more offerings, any combination of common stock, preferred stock, warrants or units having a maximum aggregate offering price of $200,000,000.

8-K filing: cbdMD, Inc. issued an aggregate of 444,243 shares of its common stock to members of CBD Holding, LLC on February 28, 2022, as partial merger consideration for the Merger Agreement, exempt from registration under Section 4(a)(2) of the Securities Act of 1933.

10-Q filing | 57.8M shares outstanding

8-K filing: On December 28, 2021, cbdMD, Inc. issued an aggregate of 466,713 shares of common stock to members of CBD Holding, LLC as part of the earnout rights from the 2018 merger agreement with Cure Based Development, LLC, after determining that the net revenues for the September 30, 2021 quarter met the criteria.

10-K filing | 54.9M shares outstanding

8-K filing: On August 16, 2021, an aggregate of 503,275 shares of common stock were issued to members following the completion of the June 30, 2021 quarter.

10-Q filing | 56.7M shares outstanding

8-K filing: cbdMD, Inc. acquired DirectCBDOnline.com in exchange for $2,000,000 and up to 600,000 shares of the company's restricted common stock.

10-Q filing | 52.8M shares outstanding

10-Q filing | 52.1M shares outstanding

10-K filing | 27.7M shares outstanding

10-Q filing | 51.3M shares outstanding

10-Q filing | 51.3M shares outstanding

10-Q filing | 46.2M shares outstanding